SANTA CLARA, Calif.–(BUSINESS WIRE)–HeartBeam Initiates Pilot Study of First On-Demand 12-Lead ECG Patch to Detect Ischemia Outside the Clinic
Rhythm
RingConn Gen 3 Smart Ring Opens for Pre-Order: Bringing Vascular Insights to Effortless Everyday Wear
World’s Leading Provider of Cutting-Edge Smart Ring Solutions NEW YORK, May 10, 2026 /PRNewswire/ — RingConn opened Gen 3 pre-orders on May 5th ahead of its official May 29th launch, marking the occasion with a feature on the iconic One Times Square billboard in New York City on the…
AccurKardia’s AK+ Guard™ Named “Best New ECG Technology Solution” By MedTech Breakthrough
NEW YORK–(BUSINESS WIRE)– #Cardiology–AccurKardia, an innovator in ECG-based diagnostics technology, today announced that AK+ Guard™ has been selected as winner of the “Best New ECG Technology Solution” award in the 10th annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough, an independent market intelligence organization that recognizes the most innovative companies, technologies and products in the global digital health and medical technology market. AI-powered AK+ Guard hyperkale
Retia Medical Presents First Public Results for Non-Invasive Cardiac Output Algorithm
WHITE PLAINS, N.Y., May 1, 2026 /PRNewswire/ — Retia Medical today announced the first public presentation of results from its non-invasive cardiac output algorithm, which estimates cardiac output using signals from sensors already placed on patients as standard of care: a pulse oximeter…
Adagio Medical Announces Positive Pivotal Results for vCLAS® Ventricular Ablation System
LAGUNA HILLS, Calif.–(BUSINESS WIRE)—- $ADGM #Arrhythmia–Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today reported six month results from its FULCRUM-VT Investigational Device Exemption (“IDE”) clinical trial, which will be used to support the Company’s application for Food and Drug Administration (“FDA”) Premarket Approval of the vCLAS Ventricular Ablation System. The results were prese
New Study Highlights Safety and Efficacy Profile of Haemonetics’ VASCADE MVP® XL in Large-Bore Venous Access Closure Procedures
BOSTON, April 24, 2026 /PRNewswire/ — Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today announced the publication of a new study comparing its VASCADE MVP® XL vascular closure…
NEW STUDY LINKS GLP-1 MEDICATIONS TO LOWER RISK OF ATRIAL FIBRILLATION, INDEPENDENT OF WEIGHT LOSS
CHICAGO, IL, APRIL 23, 2026 – A new study analyzing data from more than 13,000 patients found that people using the increasingly popular weight-loss drugs known as GLP-1 receptor agonists (GLP-1-RAs) have a reduced risk of atrial fibrillation (AF), even after accounting for the medications’ effects on weight loss and overall […]
APPLE WATCH CAPTURES MORE PEDIATRIC ARRHYTHMIA EVENTS THAN TRADITIONAL PATCH MONITORS
CHICAGO, IL, APRIL 25, 2026 – A new study examining the accuracy of wearable technologies for capturing irregular heartbeats in children found that the Apple Watchâ can capture arrhythmia events potentially more effectively than traditional ambulatory patch rhythm monitors. Researchers presented these findings as an oral abstract today at Heart Rhythm 2026. Arrhythmias occur […]
NorthStar Mapping System Now Commercially Available in the United States
MINNEAPOLIS–(BUSINESS WIRE)– #WeareiMR–Imricor Medical Systems, Inc. (Company or Imricor) (ASX: IMR) is pleased to announce the U.S. commercial launch of its NorthStar® Mapping System. As the first and only cardiac mapping and guidance system designed specifically to harness the power of magnetic resonance (MR) imaging to see the heart throughout a minimally-invasive interventional procedure, NorthStar brings the field of interventional MR (iMR) to life. NorthStar provides physicians with an entirely ne
Philips launches new Bridge Plus Occlusion Balloon to help manage rare but life-threatening SVC tears during lead extraction
Clinical illustration of the Philips Bridge Plus balloon in use
Clinical illustration of the Philips Bridge Plus balloon in use
The Philips Bridge Plus Balloon, uninflated prior to use
The Philips Bridge Plus Balloon, uninflated prior to use
The inflated Philips Bridge Plus Balloon
The inflated Philips Bridge Plus Balloon
April 23, 2026 Bridge Plus was designed for rare, life-threatening emergencies to help control bleeding during superior vena cava (SVC) tears, which occur in
Recent
Popular
- No commented posts yet